PTK2 and endometrial cancer: Using a set of phosphor-kinase arrays, treatment of ERα-negative RL95-2 endometrial cancer cells with E2 for 5 minutes significantly induced phosphorylation of ERK1/2 and of FAK at Y397 (Fig. 1B).